These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 17445111)

  • 21. Migraine-related vertigo: the challenge of the basic sciences.
    Gupta VK
    Clin Neurol Neurosurg; 2005 Dec; 108(1):109-10; reply 111-2. PubMed ID: 16168558
    [No Abstract]   [Full Text] [Related]  

  • 22. Effect of tryptophan depletion on symptoms of motion sickness in migraineurs.
    Drummond PD
    Neurology; 2005 Aug; 65(4):620-2. PubMed ID: 16116130
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Motion sickness, migraine, and menstruation in mariners.
    Grunfeld EA; Price C; Goadsby PJ; Gresty MA
    Lancet; 1998 Apr; 351(9109):1106. PubMed ID: 9660592
    [No Abstract]   [Full Text] [Related]  

  • 24. Prevention of motion sickness with rizatriptan: a double-blind, placebo-controlled pilot study.
    Marcus DA; Furman JM
    Med Sci Monit; 2006 Jan; 12(1):PI1-7. PubMed ID: 16369474
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dramatic improvement of fibromyalgia symptoms after treatment with topiramate for coexisting migraine.
    Kararizou E; Anagnostou E; Triantafyllou NI
    J Clin Psychopharmacol; 2013 Oct; 33(5):721-3. PubMed ID: 23948791
    [No Abstract]   [Full Text] [Related]  

  • 26. Chronic migraine: a therapeutic challenge for clinicians.
    Irimia P; Carmona-Abellán M; Martínez-Vila E
    Expert Opin Emerg Drugs; 2012 Dec; 17(4):445-7. PubMed ID: 22998764
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Management of mal de debarquement syndrome as vestibular migraines.
    Ghavami Y; Haidar YM; Ziai KN; Moshtaghi O; Bhatt J; Lin HW; Djalilian HR
    Laryngoscope; 2017 Jul; 127(7):1670-1675. PubMed ID: 27730651
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rizatriptan for treatment of acute migraine in patients taking topiramate for migraine prophylaxis.
    Seeburger JL; Cady RK; Winner P; MacGregor A; Valade D; Ge Y; Zhang Y; Hustad CM; Strickler N; Schaefer E; Connor KM; Ho TW
    Headache; 2012 Jan; 52(1):57-67. PubMed ID: 22078129
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Migraine and motion sickness: what is the link?
    Cuomo-Granston A; Drummond PD
    Prog Neurobiol; 2010 Aug; 91(4):300-12. PubMed ID: 20416353
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of levetiracetam vs topiramate and placebo on visually evoked phase synchronization changes of alpha rhythm in migraine.
    de Tommaso M; Marinazzo D; Nitti L; Pellicoro M; Guido M; Serpino C; Stramaglia S
    Clin Neurophysiol; 2007 Oct; 118(10):2297-304. PubMed ID: 17709295
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Visual stimuli are common triggers of migraine and are associated with pattern glare.
    Harle DE; Shepherd AJ; Evans BJ
    Headache; 2006 Oct; 46(9):1431-40. PubMed ID: 17040340
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Topiramate in the prophylactic treatment of migraine in children.
    Campistol J; Campos J; Casas C; Herranz JL
    J Child Neurol; 2005 Mar; 20(3):251-3. PubMed ID: 15832623
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of the efficacy of caffeine cessation, nortriptyline, and topiramate therapy in vestibular migraine and complex dizziness of unknown etiology.
    Mikulec AA; Faraji F; Kinsella LJ
    Am J Otolaryngol; 2012; 33(1):121-7. PubMed ID: 21704423
    [TBL] [Abstract][Full Text] [Related]  

  • 34. FDA approves Topamax for migraine prevention in adolescents.
    J Pain Palliat Care Pharmacother; 2014 Jun; 28(2):191. PubMed ID: 25011147
    [No Abstract]   [Full Text] [Related]  

  • 35. History of motion sickness is predictive of childhood migraine.
    Jan MM
    J Paediatr Child Health; 1998 Oct; 34(5):483-4. PubMed ID: 9767518
    [No Abstract]   [Full Text] [Related]  

  • 36. Migraine-related vertigo: towards a distinctive entity.
    Crevits L; Bosman T
    Clin Neurol Neurosurg; 2005 Feb; 107(2):82-7. PubMed ID: 15708220
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Typical migraine or ophthalmologic emergency?
    Ybarra M; Rosenbaum T
    Am J Emerg Med; 2012 Jun; 30(5):831.e3-5. PubMed ID: 21514762
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cost effectiveness of topiramate in the prevention of migraines in the United States: an update.
    Brown JS; Rupnow MF; Neumann P; Friedman M; Menzin J
    Manag Care Interface; 2006 Dec; 19(12):31-8. PubMed ID: 17274479
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Topiramate in migraine prophylaxis: data from a pooled analysis and open-label extension study.
    Bussone G; Usai S; D'Amico D
    Neurol Sci; 2006 May; 27 Suppl 2():S159-63. PubMed ID: 16688622
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neurostabilizers for migraine prevention. From dosage administration to patient expectations.
    Wright W
    Adv Nurse Pract; 2007 Feb; 15(2):52-4, 56-8, 85. PubMed ID: 19998927
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.